Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Building a better sphingosine kinase-1 inhibitor.
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Pediatric multiple sclerosis in Venezuela.
Mobile phones and multiple sclerosis - a nationwide cohort study in denmark.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab.
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
The risk of Bipolar Disorders in Multiple Sclerosis.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.
Distribution of Brain Sodium Accumulation Correlates with Disability in Multiple Sclerosis: A Cross-sectional 23Na MR Imaging Study.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Phase 2 results of the RADIANCE trial: a randomized, double-blind, placebo-controlled trial of oral RPC1063 in relapsing multiple sclerosis
Twin studies and the heritability of MS: a conclusion.
Anti-integrin therapy for multiple sclerosis.

Pages